Table 1 Cohort characteristics of n = 52 pediatric patients with ALL, n = 58 pediatric patients with HD, and n = 22 pediatric patients with Ewing sarcoma.
Diagnosis | Number of individuals | Median age at end of chemotherapy [y] (range) | Treatment protocol | Risk/therapy group | Relapse during study period | |||
|---|---|---|---|---|---|---|---|---|
Acute lymphoblastic leukemia | 52 | 7 (3–18) | AIEOP-BFM ALL 2009 | Non-HR | SR | 21 | No | 46 |
MR | 26 | |||||||
HR | 5 | Yes | 6 | |||||
Hodgkin's disease | 58 | 14 (3–18) | EuroNet-PHL-C1 EuroNet-PHL-C2 GPOH-HD 2002 Pilot HD-95 | TL-1 | 11 | No | 54 | |
TL-2 | 18 | |||||||
TL-3 | 29 | Yes | 4 | |||||
Ewing sarcoma | 22 | 12 (3–18) | EWING 2008 Euro-EWING 99 | R1 | 16 | No | 18 | |
R1 | 6 | Yes | 4 | |||||
